Congenital hyperinsulinemic hypoglycaemia in a neonate: a rare homozygous ABCC8 gene mutation

Chandra Prabha1, Shalini Tripathi2, Arpita Bhriguvanshi2

  • 1Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, India dr.chandraprabha9@gmail.com.

BMJ Case Reports
|May 11, 2025
PubMed

Insights

Congenital hyperinsulinism (CHI) is a rare cause of persistent hyperinsulinemic hypoglycemia in infants. Genetic diagnosis and timely management, including octreotide and cornstarch, are crucial for preventing neurological issues.

Area of Science:

  • Pediatric Endocrinology
  • Medical Genetics
  • Neonatology

Background:

  • Hyperinsulinemic hypoglycemia (HH) is a serious condition in neonates and infants.
  • Congenital hyperinsulinism (CHI) arises from genetic defects in pancreatic beta-cells, affecting KATP channels.
  • ABCC8 and KCNJ11 are key genes implicated in CHI.

Purpose of the Study:

  • To present a case of congenital hyperinsulinism in a neonate.
  • To highlight the diagnostic and therapeutic challenges and outcomes.
  • To emphasize the importance of genetic testing and tailored management.

Main Methods:

  • Clinical case presentation of a neonate with persistent hypoglycemia.
  • Genetic analysis identifying a homozygous pathogenic variant in the ABCC8 gene.
  • Management strategies including glucose infusions, diazoxide, octreotide, and cornstarch therapy.

Main Results:

  • A neonate diagnosed with CHI due to a homozygous ABCC8 variant (c.4253G>A, p.Arg1418His).
  • Initial refractoriness to standard treatments.
  • Successful response to octreotide therapy, cornstarch, and careful feeding regimen, avoiding surgery.

Conclusions:

  • Genetic diagnosis is essential for identifying the cause of congenital hyperinsulinism.
  • Timely and individualized management, including novel therapeutic approaches, can prevent severe complications.
  • This case highlights the efficacy of octreotide and cornstarch in managing refractory CHI.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
109
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
813
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
142
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K